Clinical Trial Update: A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of AMG 403 in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• AMG 403

Snippet

Sponsor: Amgen | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED